Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...
Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers ...
Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers ...
A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...
A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...
NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...
According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing ...
Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results